UNSPSC 51262412: Procaterol hydrochloride hemihydrate

This classification denotes an adrenergic beta-2 receptor agonist, bronchodilator agent, and sympathomimetic with the molecular formula 2C16H22N2O3.2ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8404I5HKFJ, chemically known as 2(1h)-quinolinone, 8-hydroxy-5-((1r,2s)-1-hydroxy-2-((1-methylethyl)amino)butyl)-, hydrochloride, hydrate (2:2:1), rel-, but more generally known as procaterol hydrochloride hemihydrate, which bears US NIH Compound Identifier 6917801.

UNSPSC 51262412 Procaterol hydrochloride hemihydrate is a Commodity code covering a specific pharmaceutical active ingredient used in bronchodilator medications, but recent state and local solicitations tagged under this code do not reflect procurement of procaterol itself. Instead, the tagged opportunities show mismatch: Seminole County, Florida is soliciting naloxone and drug deactivation systems, and the Texas Health and Human Services Commission has issued a Request for Information on direct-to-manufacturer pharmacy benefit programs. Neither procurement involves procaterol hydrochloride hemihydrate as a line item or core deliverable. The code shows little relevant recent activity aligned with its nominal scope.

The Seminole County opportunity (IFB 60459723LAS, due July 26, 2023) targets naloxone units and safe drug deactivation systems on an annual basis with quarterly deliveries to a county health facility, representing a community health initiative focused on opioid response and drug disposal rather than pharmaceutical active ingredients. The Texas HHS RFI (HHS0017013, posted April 3, 2026) explores vendor capacity for direct-to-manufacturer prescription fulfillment and negotiated net pricing models, addressing pharmacy benefit program infrastructure at the state level rather than the procurement of specific drug compounds. No other recent state or local opportunities under this code appear in the source, and the geographic and issuing-body signals are too limited and misaligned to support a meaningful market characterization. Firms pursuing work under this UNSPSC code should verify that procaterol hydrochloride hemihydrate itself is the actual procurement target, as current state and local tagging does not support active demand for this commodity.